학술논문

CD38-targeted therapy with daratumumab reduces autoantibody levels in multiple myeloma patients
Document Type
Article
Source
In: Journal of Translational Autoimmunity. (Journal of Translational Autoimmunity, December 2019, 2)
Subject
Language
English
ISSN
25899090